๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comprehensive 4-year follow-up on a case of maternal heterodisomy for chromosome 16

โœ Scribed by Schneider, Adele S.; Bischoff, Farideh Z.; McCaskill, Christopher; Coady, Mary Luz; Stopfer, Jill E.; Shaffer, Lisa G.


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
561 KB
Volume
66
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

โœฆ Synopsis


Uniparental disomy for chromosome 16 has been previously identified in fetal deaths and newborn infants with limited follow-up. Thus there is a lack of information about the long-term effects of maternal uniparental disomy 16 on growth and development. We present a case of maternal heterodisomy for chromosome 16 and a comprehensive 4-year physical and cognitive evaluation.

Cytogenetic analysis of chorionic villus obtained at 10 weeks gestation for advanced maternal age showed trisomy 16. At 15 weeks, amniocentesis demonstrated low level mosaicism 47,XY,+ 16[11/46,XY[251. Decreased fetal growth was noted in the last 2 months of pregnancy and the infant was small for gestational age at birth. Molecular studies revealed only maternal alleles for chromosome 16 in a peripheral blood sample from the child, consistent with maternal uniparental heterodisomy 16. Although short stature remains a concern, there appears to be no major cognitive effects of maternal disomy 16. Clinical evaluation and follow-up on additional cases should further clarify the role of placental mosaicism and maternal disomy 16 in intrauterine growth retardation and its effects on long-term growth in childhood.


๐Ÿ“œ SIMILAR VOLUMES


The earlier diagnosis of adenocarcinoma
โœ Victor A. Gilbertsen ๐Ÿ“‚ Article ๐Ÿ“… 1971 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 573 KB

From 1940 to 1963, 1,884 patients with adenocarcinomas of the large intestine (including colon and rectum) were seen at the University of Minnesota Medical Center. Patients with lesions of the rectum comprised 53.2% of the group and numbered 1,002, including 693 (36.8%) with cancers of the rectal am